Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
323.9 USD | -1.63% |
|
+4.13% | +47.29% |
Jul. 11 | TD Cowen Adjusts Price Target on United Therapeutics to $350 From $270, Maintains Buy Rating | MT |
Jul. 11 | Everything's going according to plan | ![]() |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+47.29% | 14.37B | |
+23.50% | 47.07B | |
+47.36% | 42.06B | |
-5.16% | 39.98B | |
+36.37% | 33.02B | |
-7.79% | 27.9B | |
+18.06% | 27.63B | |
+41.91% | 13.45B | |
-1.02% | 12.03B | |
-10.80% | 10.86B |
- Stock Market
- Equities
- UTHR Stock
- News United Therapeutics Corporation
- Tempus, United Therapeutics Launch Collaboration to Use AI to Detect Risk of Pulmonary Hypertension